497 related articles for article (PubMed ID: 24122375)
41. miRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin.
Chen WS; Yen CJ; Chen YJ; Chen JY; Wang LY; Chiu SJ; Shih WL; Ho CY; Wei TT; Pan HL; Chien PH; Hung MC; Chen CC; Huang WC
Oncotarget; 2015 Sep; 6(28):25962-74. PubMed ID: 26296971
[TBL] [Abstract][Full Text] [Related]
42. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.
Xie Q; Chen L; Shan X; Shan X; Tang J; Zhou F; Chen Q; Quan H; Nie D; Zhang W; Huang AL; Tang N
Int J Cancer; 2014 Aug; 135(3):635-46. PubMed ID: 24374650
[TBL] [Abstract][Full Text] [Related]
43. Pleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma.
Bai PS; Xia N; Sun H; Kong Y
J Cell Mol Med; 2017 Nov; 21(11):3023-3043. PubMed ID: 28557334
[TBL] [Abstract][Full Text] [Related]
44. HBx/ERα complex-mediated LINC01352 downregulation promotes HBV-related hepatocellular carcinoma via the miR-135b-APC axis.
Huang P; Xu Q; Yan Y; Lu Y; Hu Z; Ou B; Zhang H; Mao K; Zhang J; Wang J; Xiao Z
Oncogene; 2020 Apr; 39(18):3774-3789. PubMed ID: 32157216
[TBL] [Abstract][Full Text] [Related]
45. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein.
Zhang S; Gao S; Zhao M; Liu Y; Bu Y; Jiang Q; Zhao Q; Ye L; Zhang X
Cancer Lett; 2017 Apr; 392():94-104. PubMed ID: 28192212
[TBL] [Abstract][Full Text] [Related]
46. [The expression of hepatitis B virus X protein and cyclooxygenase-2 in hepatitis B virus-related hepatocellular carcinoma: correlation with microangiogenesis and metastasis, and what is the possible mechanism].
Liu KG; Shao XL; Xie HH; Xu L; Zhao H; Guo ZH; Li L; Liu J
Zhonghua Gan Zang Bing Za Zhi; 2010 Nov; 18(11):831-6. PubMed ID: 21138631
[TBL] [Abstract][Full Text] [Related]
47. Metformin inhibits tumorigenesis in HBV-induced hepatocellular carcinoma by suppressing HULC overexpression caused by HBX.
Jiang Z; Liu H
J Cell Biochem; 2018 Jun; 119(6):4482-4495. PubMed ID: 29231260
[TBL] [Abstract][Full Text] [Related]
48. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
Li J; Dai X; Zhang H; Zhang W; Sun S; Gao T; Kou Z; Yu H; Guo Y; Du L; Jiang S; Zhang J; Zhou Y
Oncotarget; 2015 Oct; 6(30):29196-208. PubMed ID: 26470691
[TBL] [Abstract][Full Text] [Related]
49. HBx mediated Increase of SIRT1 Contributes to HBV-related Hepatocellular Carcinoma Tumorigenesis.
Wang Q; Cheng ST; Chen J
Int J Med Sci; 2020; 17(12):1783-1794. PubMed ID: 32714081
[No Abstract] [Full Text] [Related]
50. The miR-545/374a cluster encoded in the Ftx lncRNA is overexpressed in HBV-related hepatocellular carcinoma and promotes tumorigenesis and tumor progression.
Zhao Q; Li T; Qi J; Liu J; Qin C
PLoS One; 2014; 9(10):e109782. PubMed ID: 25299640
[TBL] [Abstract][Full Text] [Related]
51. Hepatitis B virus X protein stimulates high mobility group box 1 secretion and enhances hepatocellular carcinoma metastasis.
Chen S; Dong Z; Yang P; Wang X; Jin G; Yu H; Chen L; Li L; Tang L; Bai S; Yan H; Shen F; Cong W; Wen W; Wang H
Cancer Lett; 2017 May; 394():22-32. PubMed ID: 28216372
[TBL] [Abstract][Full Text] [Related]
52. Nuclear IKKα mediates microRNA-7/-103/107/21 inductions to downregulate maspin expression in response to HBx overexpression.
Chen WS; Liu LC; Yen CJ; Chen YJ; Chen JY; Ho CY; Liu SH; Chen CC; Huang WC
Oncotarget; 2016 Aug; 7(35):56309-56323. PubMed ID: 27409165
[TBL] [Abstract][Full Text] [Related]
53. Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma.
Xie Q; Chen X; Lu F; Zhang T; Hao M; Wang Y; Zhao J; McCrae MA; Zhuang H
Cancer; 2012 May; 118(9):2431-42. PubMed ID: 21989846
[TBL] [Abstract][Full Text] [Related]
54. Hepatitis B virus induces hypoxia-inducible factor-2α expression through hepatitis B virus X protein.
Hu JL; Liu LP; Yang SL; Fang X; Wen L; Ren QG; Yu C
Oncol Rep; 2016 Mar; 35(3):1443-8. PubMed ID: 26647960
[TBL] [Abstract][Full Text] [Related]
55. Hepatitis B virus X protein mutant upregulates CENP-A expression in hepatoma cells.
Liu L; Li Y; Zhang S; Yu D; Zhu M
Oncol Rep; 2012 Jan; 27(1):168-73. PubMed ID: 21956590
[TBL] [Abstract][Full Text] [Related]
56. Interaction of lncRNA-MALAT1 and miR-124 regulates HBx-induced cancer stem cell properties in HepG2 through PI3K/Akt signaling.
He B; Peng F; Li W; Jiang Y
J Cell Biochem; 2019 Mar; 120(3):2908-2918. PubMed ID: 30500989
[TBL] [Abstract][Full Text] [Related]
57. Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis.
Zhu R; Mok MT; Kang W; Lau SS; Yip WK; Chen Y; Lai PB; Wong VW; To KF; Sung JJ; Cheng AS; Chan HL
J Pathol; 2015 Sep; 237(1):38-49. PubMed ID: 25925944
[TBL] [Abstract][Full Text] [Related]
58. Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3.
Wang Y; Lu Y; Toh ST; Sung WK; Tan P; Chow P; Chung AY; Jooi LL; Lee CG
J Hepatol; 2010 Jul; 53(1):57-66. PubMed ID: 20447714
[TBL] [Abstract][Full Text] [Related]
59. USP16 Downregulation by Carboxyl-terminal Truncated HBx Promotes the Growth of Hepatocellular Carcinoma Cells.
Qian Y; Wang B; Ma A; Zhang L; Xu G; Ding Q; Jing T; Wu L; Liu Y; Yang Z; Liu Y
Sci Rep; 2016 Sep; 6():33039. PubMed ID: 27633997
[TBL] [Abstract][Full Text] [Related]
60. HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3.
Chen JY; Chen YJ; Yen CJ; Chen WS; Huang WC
Oncotarget; 2016 Jan; 7(1):473-89. PubMed ID: 26595522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
